Europe Meropenem Market Report 2016

Publisher Name :
Date: 19-Sep-2016
No. of pages: 114
Inquire Before Buying

Notes:

Sales, means the sales volume of Meropenem

Revenue, means the sales value of Meropenem

This report studies sales (consumption) of Meropenem in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

- Pfizer

- Shenzhen Haibin Pharmaceutical

- Novartis

- Mylan

- GE Healthcare

- Spectrum Chemical Manufacturing Corp

- Abbott

- Takeda

- Hisun-Pfizer Pharmaceuticals

- Haikou Pharmaceutical Factory

- Shijiazhuang Pharma

- Sumitomo Pharmaceuticals

- Sumitomo Dainippon Pharma Co.,Ltd

- Varika Chemicals & Pharmaceuticals Ltd

- Astra Zeneca Pharma India Limited

- Crucell Switzerland AG

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Meropenem in these countries, from 2011 to 2021 (forecast), like

- Germany

- France

- UK

- Russia

- Italy

- Spain

- Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Injection

- Freeze-dried powder

- Type III

Split by application, this report focuses on sales, market share and growth rate of Meropenem in each application, can be divided into

- Hospital use

- Clinic

- Others

Europe Meropenem Market Report 2016

Table of Contents
Europe Meropenem Market Report 2016
1 Meropenem Overview
1.1 Product Overview and Scope of Meropenem
1.2 Classification of Meropenem
1.2.11 Injection
1.2.12 Freeze-dried powder
1.2.3 Type III
1.3 Application of Meropenem
1.3.11 Hospital use
1.3.12 Clinic
1.3.13 Others
1.4 Meropenem Market by Countries
1.4.1 Germany Status and Prospect (2011-2021)
1.4.2 France Status and Prospect (2011-2021)
1.4.3 UK Status and Prospect (2011-2021)
1.4.4 Russia Status and Prospect (2011-2021)
1.4.5 Italy Status and Prospect (2011-2021)
1.4.6 Spain Status and Prospect (2011-2021)
1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Meropenem (2011-2021)
1.5.1 Europe Meropenem Sales and Growth Rate (2011-2021)
1.5.2 Europe Meropenem Revenue and Growth Rate (2011-2021)
2 Europe Meropenem by Manufacturers, Type and Application
2.1 Europe Meropenem Market Competition by Manufacturers
2.1.1 Europe Meropenem Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Meropenem Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Meropenem (Volume and Value) by Type
2.2.1 Europe Meropenem Sales and Market Share by Type (2011-2016)
2.2.2 Europe Meropenem Revenue and Market Share by Type (2011-2016)
2.3 Europe Meropenem (Volume and Value) by Countries
2.3.1 Europe Meropenem Sales and Market Share by Countries (2011-2016)
2.3.2 Europe Meropenem Revenue and Market Share by Countries (2011-2016)
2.4 Europe Meropenem (Volume) by Application
3 Germany Meropenem (Volume, Value and Sales Price)
3.1 Germany Meropenem Sales and Value (2011-2016)
3.1.1 Germany Meropenem Sales and Growth Rate (2011-2016)
3.1.2 Germany Meropenem Revenue and Growth Rate (2011-2016)
3.1.3 Germany Meropenem Sales Price Trend (2011-2016)
3.2 Germany Meropenem Sales and Market Share by Manufacturers
3.3 Germany Meropenem Sales and Market Share by Type
3.4 Germany Meropenem Sales and Market Share by Application
4 France Meropenem (Volume, Value and Sales Price)
4.1 France Meropenem Sales and Value (2011-2016)
4.1.1 France Meropenem Sales and Growth Rate (2011-2016)
4.1.2 France Meropenem Revenue and Growth Rate (2011-2016)
4.1.4 France Meropenem Sales Price Trend (2011-2016)
4.2 France Meropenem Sales and Market Share by Manufacturers
4.3 France Meropenem Sales and Market Share by Type
4.4 France Meropenem Sales and Market Share by Application
5 UK Meropenem (Volume, Value and Sales Price)
5.1 UK Meropenem Sales and Value (2011-2016)
5.1.1 UK Meropenem Sales and Growth Rate (2011-2016)
5.1.2 UK Meropenem Revenue and Growth Rate (2011-2016)
5.1.5 UK Meropenem Sales Price Trend (2011-2016)
5.2 UK Meropenem Sales and Market Share by Manufacturers
5.3 UK Meropenem Sales and Market Share by Type
5.4 UK Meropenem Sales and Market Share by Application
6 Russia Meropenem (Volume, Value and Sales Price)
6.1 Russia Meropenem Sales and Value (2011-2016)
6.1.1 Russia Meropenem Sales and Growth Rate (2011-2016)
6.1.2 Russia Meropenem Revenue and Growth Rate (2011-2016)
6.1.6 Russia Meropenem Sales Price Trend (2011-2016)
6.2 Russia Meropenem Sales and Market Share by Manufacturers
6.3 Russia Meropenem Sales and Market Share by Type
6.4 Russia Meropenem Sales and Market Share by Application
7 Italy Meropenem (Volume, Value and Sales Price)
7.1 Italy Meropenem Sales and Value (2011-2016)
7.1.1 Italy Meropenem Sales and Growth Rate (2011-2016)
7.1.2 Italy Meropenem Revenue and Growth Rate (2011-2016)
7.1.7 Italy Meropenem Sales Price Trend (2011-2016)
7.2 Italy Meropenem Sales and Market Share by Manufacturers
7.3 Italy Meropenem Sales and Market Share by Type
7.4 Italy Meropenem Sales and Market Share by Application
8 Spain Meropenem (Volume, Value and Sales Price)
8.1 Spain Meropenem Sales and Value (2011-2016)
8.1.1 Spain Meropenem Sales and Growth Rate (2011-2016)
8.1.2 Spain Meropenem Revenue and Growth Rate (2011-2016)
8.1.8 Spain Meropenem Sales Price Trend (2011-2016)
8.2 Spain Meropenem Sales and Market Share by Manufacturers
8.3 Spain Meropenem Sales and Market Share by Type
8.4 Spain Meropenem Sales and Market Share by Application
9 Benelux Meropenem (Volume, Value and Sales Price)
9.1 Benelux Meropenem Sales and Value (2011-2016)
9.1.1 Benelux Meropenem Sales and Growth Rate (2011-2016)
9.1.2 Benelux Meropenem Revenue and Growth Rate (2011-2016)
9.1.9 Benelux Meropenem Sales Price Trend (2011-2016)
9.2 Benelux Meropenem Sales and Market Share by Manufacturers
9.3 Benelux Meropenem Sales and Market Share by Type
9.4 Benelux Meropenem Sales and Market Share by Application
10 Europe Meropenem Manufacturers Analysis
10.1 Pfizer
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Meropenem Product Type, Application and Specification
10.1.2.1 Type I
10.1.2.2 Type II
10.1.3 Pfizer Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
10.1.4 Main Business/Business Overview
10.2 Shenzhen Haibin Pharmaceutical
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Meropenem Product Type, Application and Specification
10.2.2.1 Type I
10.2.2.2 Type II
10.2.3 Shenzhen Haibin Pharmaceutical Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
10.2.4 Main Business/Business Overview
10.3 Novartis
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Meropenem Product Type, Application and Specification
10.3.2.1 Type I
10.3.2.2 Type II
10.3.3 Novartis Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
10.3.4 Main Business/Business Overview
10.4 Mylan
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Meropenem Product Type, Application and Specification
10.4.2.1 Type I
10.4.2.2 Type II
10.4.3 Mylan Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
10.4.4 Main Business/Business Overview
10.5 GE Healthcare
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Meropenem Product Type, Application and Specification
10.5.2.1 Type I
10.5.2.2 Type II
10.5.3 GE Healthcare Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
10.5.4 Main Business/Business Overview
10.6 Spectrum Chemical Manufacturing Corp
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Meropenem Product Type, Application and Specification
10.6.2.1 Type I
10.6.2.2 Type II
10.6.3 Spectrum Chemical Manufacturing Corp Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
10.6.4 Main Business/Business Overview
10.7 Abbott
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Meropenem Product Type, Application and Specification
10.7.2.1 Type I
10.7.2.2 Type II
10.7.3 Abbott Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
10.7.4 Main Business/Business Overview
10.8 Takeda
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Meropenem Product Type, Application and Specification
10.8.2.1 Type I
10.8.2.2 Type II
10.8.3 Takeda Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
10.8.4 Main Business/Business Overview
10.9 Hisun-Pfizer Pharmaceuticals
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Meropenem Product Type, Application and Specification
10.9.2.1 Type I
10.9.2.2 Type II
10.9.3 Hisun-Pfizer Pharmaceuticals Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
10.9.4 Main Business/Business Overview
10.10 Haikou Pharmaceutical Factory
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Meropenem Product Type, Application and Specification
10.10.2.1 Type I
10.10.2.2 Type II
10.10.3 Haikou Pharmaceutical Factory Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
10.10.4 Main Business/Business Overview
10.11 Shijiazhuang Pharma
10.12 Sumitomo Pharmaceuticals
10.13 Sumitomo Dainippon Pharma Co.,Ltd
10.14 Varika Chemicals & Pharmaceuticals Ltd
10.15 Astra Zeneca Pharma India Limited
10.16 Crucell Switzerland AG
11 Meropenem Manufacturing Cost Analysis
11.1 Meropenem Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Meropenem
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Meropenem Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Meropenem Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe Meropenem Market Forecast (2016-2021)
14.1 Germany Meropenem Sales Forecast (2016-2021)
14.2 France Meropenem Sales Forecast (2016-2021)
14.3 UK Meropenem Sales Forecast (2016-2021)
14.4 Russia Meropenem Sales Forecast (2016-2021)
14.5 Italy Meropenem Sales Forecast (2016-2021)
14.6 Spain Meropenem Sales Forecast (2016-2021)
14.7 Benelux Meropenem Sales Forecast (2016-2021)
14.8 Europe Meropenem Sales Forecast by Type (2016-2021)
14.9 Europe Meropenem Sales Forecast by Application (2016-2021)
15 Research Findings and Conclusion
16 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Meropenem
Table Classification of Meropenem
Figure Europe Sales Market Share of Meropenem by Type in 2015
Figure Injection Picture
Figure Freeze-dried powder Picture
Table Application of Meropenem
Figure Europe Sales Market Share of Meropenem by Application in 2015
Figure Hospital use Examples
Figure Clinic Examples
Figure Others Examples
Figure Germany Meropenem Revenue and Growth Rate (2011-2021)
Figure France Meropenem Revenue and Growth Rate (2011-2021)
Figure UK Meropenem Revenue and Growth Rate (2011-2021)
Figure Russia Meropenem Revenue and Growth Rate (2011-2021)
Figure Italy Meropenem Revenue and Growth Rate (2011-2021)
Figure Spain Meropenem Revenue and Growth Rate (2011-2021)
Figure Benelux Meropenem Revenue and Growth Rate (2011-2021)
Figure Europe Meropenem Sales and Growth Rate (2011-2021)
Figure Europe Meropenem Revenue and Growth Rate (2011-2021)
Table Europe Meropenem Sales of Key Manufacturers (2015 and 2016)
Table Europe Meropenem Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Meropenem Sales Share by Manufacturers
Figure 2016 Meropenem Sales Share by Manufacturers
Table Europe Meropenem Revenue by Manufacturers (2015 and 2016)
Table Europe Meropenem Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Meropenem Revenue Share by Manufacturers
Table 2016 Europe Meropenem Revenue Share by Manufacturers
Table Europe Meropenem Sales and Market Share by Type (2011-2016)
Table Europe Meropenem Sales Share by Type (2011-2016)
Figure Sales Market Share of Meropenem by Type (2011-2016)
Figure Europe Meropenem Sales Growth Rate by Type (2011-2016)
Table Europe Meropenem Revenue and Market Share by Type (2011-2016)
Table Europe Meropenem Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Meropenem by Type (2011-2016)
Figure Europe Meropenem Revenue Growth Rate by Type (2011-2016)
Table Europe Meropenem Sales and Market Share by Countries (2011-2016)
Table Europe Meropenem Sales Share by Countries (2011-2016)
Figure Sales Market Share of Meropenem by Countries (2011-2016)
Table Europe Meropenem Revenue and Market Share by Countries (2011-2016)
Table Europe Meropenem Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Meropenem by Countries (2011-2016)
Table Europe Meropenem Sales and Market Share by Application (2011-2016)
Table Europe Meropenem Sales Share by Application (2011-2016)
Figure Sales Market Share of Meropenem by Application (2011-2016)
Figure Germany Meropenem Sales and Growth Rate (2011-2016)
Figure Germany Meropenem Revenue and Growth Rate (2011-2016)
Figure Germany Meropenem Sales Price Trend (2011-2016)
Table Germany Meropenem Sales by Manufacturers (2015 and 2016)
Table Germany Meropenem Market Share by Manufacturers (2015 and 2016)
Table Germany Meropenem Sales by Type (2015 and 2016)
Table Germany Meropenem Market Share by Type (2015 and 2016)
Table Germany Meropenem Sales by Application (2015 and 2016)
Table Germany Meropenem Market Share by Application (2015 and 2016)
Figure France Meropenem Sales and Growth Rate (2011-2016)
Figure France Meropenem Revenue and Growth Rate (2011-2016)
Figure France Meropenem Sales Price Trend (2011-2016)
Table France Meropenem Sales by Manufacturers (2015 and 2016)
Table France Meropenem Market Share by Manufacturers (2015 and 2016)
Table France Meropenem Sales by Type (2015 and 2016)
Table France Meropenem Market Share by Type (2015 and 2016)
Table France Meropenem Sales by Application (2015 and 2016)
Table France Meropenem Market Share by Application (2015 and 2016)
Figure UK Meropenem Sales and Growth Rate (2011-2016)
Figure UK Meropenem Revenue and Growth Rate (2011-2016)
Figure UK Meropenem Sales Price Trend (2011-2016)
Table UK Meropenem Sales by Manufacturers (2015 and 2016)
Table UK Meropenem Market Share by Manufacturers (2015 and 2016)
Table UK Meropenem Sales by Type (2015 and 2016)
Table UK Meropenem Market Share by Type (2015 and 2016)
Table UK Meropenem Sales by Application (2015 and 2016)
Table UK Meropenem Market Share by Application (2015 and 2016)
Figure Russia Meropenem Sales and Growth Rate (2011-2016)
Figure Russia Meropenem Revenue and Growth Rate (2011-2016)
Figure Russia Meropenem Sales Price Trend (2011-2016)
Table Russia Meropenem Sales by Manufacturers (2015 and 2016)
Table Russia Meropenem Market Share by Manufacturers (2015 and 2016)
Table Russia Meropenem Sales by Type (2015 and 2016)
Table Russia Meropenem Market Share by Type (2015 and 2016)
Table Russia Meropenem Sales by Application (2015 and 2016)
Table Russia Meropenem Market Share by Application (2015 and 2016)
Figure Italy Meropenem Sales and Growth Rate (2011-2016)
Figure Italy Meropenem Revenue and Growth Rate (2011-2016)
Figure Italy Meropenem Sales Price Trend (2011-2016)
Table Italy Meropenem Sales by Manufacturers (2015 and 2016)
Table Italy Meropenem Market Share by Manufacturers (2015 and 2016)
Table Italy Meropenem Sales by Type (2015 and 2016)
Table Italy Meropenem Market Share by Type (2015 and 2016)
Table Italy Meropenem Sales by Application (2015 and 2016)
Table Italy Meropenem Market Share by Application (2015 and 2016)
Figure Spain Meropenem Sales and Growth Rate (2011-2016)
Figure Spain Meropenem Revenue and Growth Rate (2011-2016)
Figure Spain Meropenem Sales Price Trend (2011-2016)
Table Spain Meropenem Sales by Manufacturers (2015 and 2016)
Table Spain Meropenem Market Share by Manufacturers (2015 and 2016)
Table Spain Meropenem Sales by Type (2015 and 2016)
Table Spain Meropenem Market Share by Type (2015 and 2016)
Table Spain Meropenem Sales by Application (2015 and 2016)
Table Spain Meropenem Market Share by Application (2015 and 2016)
Figure Benelux Meropenem Sales and Growth Rate (2011-2016)
Figure Benelux Meropenem Revenue and Growth Rate (2011-2016)
Figure Benelux Meropenem Sales Price Trend (2011-2016)
Table Benelux Meropenem Sales by Manufacturers (2015 and 2016)
Table Benelux Meropenem Market Share by Manufacturers (2015 and 2016)
Table Benelux Meropenem Sales by Type (2015 and 2016)
Table Benelux Meropenem Market Share by Type (2015 and 2016)
Table Benelux Meropenem Sales by Application (2015 and 2016)
Table Benelux Meropenem Market Share by Application (2015 and 2016)
Table Meropenem Basic Information List
Table Pfizer Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Meropenem Sales Market Share (2011-2016)
Table Shenzhen Haibin Pharmaceutical Basic Information List
Table Shenzhen Haibin Pharmaceutical Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shenzhen Haibin Pharmaceutical Meropenem Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Meropenem Sales Market Share (2011-2016)
Table Mylan Basic Information List
Table Mylan Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mylan Meropenem Sales Market Share (2011-2016)
Table GE Healthcare Basic Information List
Table GE Healthcare Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Table GE Healthcare Meropenem Sales Market Share (2011-2016)
Table Spectrum Chemical Manufacturing Corp Basic Information List
Table Spectrum Chemical Manufacturing Corp Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Table Spectrum Chemical Manufacturing Corp Meropenem Sales Market Share (2011-2016)
Table Abbott Basic Information List
Table Abbott Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Meropenem Sales Market Share (2011-2016)
Table Takeda Basic Information List
Table Takeda Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Table Takeda Meropenem Sales Market Share (2011-2016)
Table Hisun-Pfizer Pharmaceuticals Basic Information List
Table Hisun-Pfizer Pharmaceuticals Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hisun-Pfizer Pharmaceuticals Meropenem Sales Market Share (2011-2016)
Table Haikou Pharmaceutical Factory Basic Information List
Table Haikou Pharmaceutical Factory Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Table Haikou Pharmaceutical Factory Meropenem Sales Market Share (2011-2016)
Table Shijiazhuang Pharma Basic Information List
Table Shijiazhuang Pharma Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shijiazhuang Pharma Meropenem Sales Market Share (2011-2016)
Table Sumitomo Pharmaceuticals Basic Information List
Table Sumitomo Pharmaceuticals Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sumitomo Pharmaceuticals Meropenem Sales Market Share (2011-2016)
Table Sumitomo Dainippon Pharma Co.,Ltd Basic Information List
Table Sumitomo Dainippon Pharma Co.,Ltd Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sumitomo Dainippon Pharma Co.,Ltd Meropenem Sales Market Share (2011-2016)
Table Varika Chemicals & Pharmaceuticals Ltd Basic Information List
Table Varika Chemicals & Pharmaceuticals Ltd Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Table Varika Chemicals & Pharmaceuticals Ltd Meropenem Sales Market Share (2011-2016)
Table Astra Zeneca Pharma India Limited Basic Information List
Table Astra Zeneca Pharma India Limited Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Table Astra Zeneca Pharma India Limited Meropenem Sales Market Share (2011-2016)
Table Crucell Switzerland AG Basic Information List
Table Crucell Switzerland AG Meropenem Sales, Revenue, Price and Gross Margin (2011-2016)
Table Crucell Switzerland AG Meropenem Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Meropenem
Figure Manufacturing Process Analysis of Meropenem
Figure Meropenem Industrial Chain Analysis
Table Raw Materials Sources of Meropenem Major Manufacturers in 2015
Table Major Buyers of Meropenem
Table Distributors/Traders List
Figure Germany Meropenem Sales and Growth Rate Forecast (2016-2021)
Figure Germany Meropenem Revenue and Growth Rate Forecast (2016-2021)
Figure France Meropenem Sales and Growth Rate Forecast (2016-2021)
Figure France Meropenem Revenue and Growth Rate Forecast (2016-2021)
Figure UK Meropenem Sales and Growth Rate Forecast (2016-2021)
Figure UK Meropenem Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Meropenem Sales and Growth Rate Forecast (2016-2021)
Figure Russia Meropenem Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Meropenem Sales and Growth Rate Forecast (2016-2021)
Figure Italy Meropenem Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Meropenem Sales and Growth Rate Forecast (2016-2021)
Figure Spain Meropenem Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Meropenem Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Meropenem Revenue and Growth Rate Forecast (2016-2021)
Table Europe Meropenem Sales Forecast by Type (2016-2021)
Table Europe Meropenem Sales Forecast by Application (2016-2021)
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • Global Compounding Pharmacy Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 25-May-2017        Price: US 3480 Onwards        Pages: 116
    The traditional role of compounding pharmacies is to make drugs prescribed by doctors for specific patients with needs that can't be met by commercially available drugs. For example: A young child may need a small, liquid dose of a drug made only in adult-dosage tablets. A person may be allergic to one of the ingredients in the commercial version of a drug. A compounding pharmacy would make the proper dosage and form of the drug without any offending ......
  • Global Knee Replacement Implants Sales Market Report 2017
    Published: 24-May-2017        Price: US 4000 Onwards        Pages: 116
    In this report, the global Knee Replacement Implants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Knee Replacement Implants for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe......
  • Global Flu Vaccine Sales Market Report 2017
    Published: 24-May-2017        Price: US 4000 Onwards        Pages: 113
    In this report, the global Flu Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Flu Vaccine for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan - South......
  • Global Companion Animal Speciality Drugs Market Size, Status and Forecast 2022
    Published: 24-May-2017        Price: US 3300 Onwards        Pages: 101
    This report studies the global Companion Animal Speciality Drugs market, analyzes and researches the Companion Animal Speciality Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Zoetis - Merck - Merial - Elanco - Bayer Animal Health - Boehringer Ingelheim Vetmedica - Virbac - Ceva Sante Animale - Vétoquinol - Juro......
  • Global Communicable Diseases Treatment Market Size, Status and Forecast 2022
    Published: 24-May-2017        Price: US 3300 Onwards        Pages: 106
    This report studies the global Communicable Diseases Treatment market, analyzes and researches the Communicable Diseases Treatment development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Bristol-Myers Squibb Pharmaceutical - Eli Lilly - GlaxoSmithKline - Johnson & Johnson - Medtronic - Merck - Pfizer - F. Hoffmann-La Roche - Sanofi......
  • Global Human Vaccine Market Research Report 2017
    Published: 24-May-2017        Price: US 2900 Onwards        Pages: 118
    In this report, the global Human Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Human Vaccine in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan......
  • Global Gamma Globulin Market Research Report 2017
    Published: 24-May-2017        Price: US 2900 Onwards        Pages: 109
    In this report, the global Gamma Globulin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Gamma Globulin in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan......
  • Global Trazodone Hydrochloride (API) Market Research Report 2017
    Published: 24-May-2017        Price: US 2900 Onwards        Pages: 102
    In this report, the global Trazodone Hydrochloride (API) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Trazodone Hydrochloride (API) in these regions, from 2012 to 2022 (forecast), covering - North America - Europe......
  • Global Ostomy Products Market Research Report 2017
    Published: 24-May-2017        Price: US 2900 Onwards        Pages: 117
    In this report, the global Ostomy Products market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Ostomy Products in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Jap......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs